Riskpilot← Back to searchSign inGet full accessLead Biologics International AB
ABActiveOrg 5594017971LundResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20222 employees
Revenue 2025
SEK 11K
-83% vs 2024
EBITDA margin
-21018.2%
-76% vs 2024
Equity ratio
82.6%
Financial strength
Net profit 2025
SEK -2,3M
-75% vs 2024
| Revenue | SEK 11K | -83% |
| EBITDA | SEK -2,3M | -76% |
| Net profit | SEK -2,3M | -75% |
| Total assets | SEK 5,3M | +291% |
| Equity | SEK 4,4M | +565% |
| Employees | 2 | — |
Legal name
Lead Biologics International AB
Org number
5594017971
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19 oktober 2022
Share capital
SEK 36 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska direkt eller indirekt, bedriva forskning, utveckling och försäljning av medicinska produkter och rättigheter, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Lund
Email
anki.m.hager@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 65 | 11 |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | −50 | — | −415 | −1 313 | −2 312 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −50 | −50 | −415 | −1 313 | −2 312 |
| Net financials | — | — | — | 3 | 14 |
| Profit before tax | −50 | — | −415 | −1 311 | −2 298 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −50 | −50 | −415 | −1 311 | −2 298 |
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 512 | 512 | 2 302 | 1 350 | 5 276 |
| Equity | 425 | 425 | 1 966 | 655 | 4 357 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 87 | 87 | 336 | 695 | 919 |
| Total debt | 87 | 87 | 336 | 695 | 919 |
EBITDA margin
-21018.2%
This company
15.8%
Market median
-133127% vs market
20222025
Equity ratio
82.6%
This company
38.2%
Market median
+116% vs market
20222025
Return on equity
-52.7%
This company
18.4%
Market median
-386% vs market
20222025
Net profit margin
-20890.9%
This company
8.1%
Market median
-258012% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-10-19 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-10-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CA Chief Executive Officer | Chief Executive Officer | 2022 |
PH Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2026 | |
| Board of Directors | 2024 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lead Biologics International AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cecilia Ann-Christin Malmborg Hager | Chief Executive Officer | 0 companies |
| Pär Henrik Rosengren | Chief Auditor | 0 companies |
| Kjell Torsten Sjöström | Board of Directors | 0 companies |
| Carl Casper Sandén | Board of Directors | 0 companies |
| Per Niklas Landberg | Board of Directors | 0 companies |
| Thoas Michael Fioretos | Chairman | 0 companies |
| Marcus Anders Järås | Board of Directors | 0 companies |
| Helen Monika Pettersson | Board of Directors | 0 companies |
| Lars Henrik Bruzelius | Board of Directors | 0 companies |
| Lars Allan Grundemar | Board of Directors | 0 companies |